Produtos das marcas Synedica e TG no tm registro e oferecem riscos sade
While the LIVE and FIGHT trials explored their effects on heart failure with reduced ejection fraction (HFrEF), the STEP-HFpEF trial demonstrated that GLP-1RAs improve HFpEF outcomes by reducing symptoms, physical limitations, and body weight [9]
Yeasen Kex2 protease and carboxypeptidase B efficiently cleave P29-Arg34 GLP-1 (937), supporting a tandem enzymatic process with high yield and high purity
Altogether, when administering GLP-1RA plus SGLT2i combination therapy, it is important to adopt an individualized approach to therapy taking into account individual preferences, costs and coverage, toxicity profile, consideration of kidney function and glucose-lowering efficacy, desire for weight loss, and comorbidities